GRI Bio annual total assets
2020
2021
2022
2023
2024
2025
GRI Bio Total Assets Growth & History (GRI)
GRI Bio's total assets was $8.7M for fiscal 2025.
View full GRI Bio company overviewGRI Bio annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.7M | $2.9M | +51.00% |
| 2024 | 2024-12-31 | $5.7M | $2.8M | +94.15% |
| 2023 | 2023-12-31 | $3.0M | $2.6M | +671.80% |
| 2022 | 2022-12-31 | $383,000 | −$8.0M | −95.40% |
| 2021 | 2021-12-31 | $8.3M | $7.4M | +772.77% |
| 2020 | 2020-12-31 | $955,000 | — | — |
GRI Bio quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $11.4M | $5.7M | +100.53% |
| Q1 2026 | 2026-03-31 | $11.3M | $7.3M | +180.53% |
| Q4 2025 | 2025-12-31 | $8.7M | $2.9M | +51.00% |
| Q3 2025 | 2025-09-30 | $4.8M | −$677,000 | −12.40% |
| Q2 2025 | 2025-06-30 | $5.7M | −$1.4M | −19.29% |
| Q1 2025 | 2025-03-31 | $4.0M | −$545,000 | −11.88% |
| Q4 2024 | 2024-12-31 | $5.7M | $2.8M | +94.15% |
| Q3 2024 | 2024-09-30 | $5.5M | $1.1M | +23.96% |
| Q2 2024 | 2024-06-30 | $7.0M | $1.4M | +24.62% |
| Q1 2024 | 2024-03-31 | $4.6M | $2.5M | +118.74% |
| Q4 2023 | 2023-12-31 | $3.0M | $2.6M | +671.80% |
| Q3 2023 | 2023-09-30 | $4.4M | −$1.2M | −20.92% |
| Q2 2023 | 2023-06-30 | $5.6M | −$2.4M | −29.54% |
| Q1 2023 | 2023-03-31 | $2.1M | −$3.8M | −64.72% |
| Q4 2022 | 2022-12-31 | $383,000 | −$8.0M | −95.40% |
| Q3 2022 | 2022-09-30 | $5.6M | −$4.6M | −45.08% |
| Q2 2022 | 2022-06-30 | $8.0M | −$3.6M | −31.25% |
| Q1 2022 | 2022-03-31 | $5.9M | −$8.7M | −59.29% |
| Q4 2021 | 2021-12-31 | $8.3M | $7.4M | +772.77% |
| Q3 2021 | 2021-09-30 | $10.1M | — | — |
| Q2 2021 | 2021-06-30 | $11.6M | — | — |
| Q1 2021 | 2021-03-31 | $14.6M | — | — |
| Q4 2020 | 2020-12-31 | $955,000 | — | — |
GRI Bio total assets trends
Over the last five fiscal years, GRI Bio's total assets increased from $955,000 to $8.7M, a change of $7.7M. The latest reported quarter, Q2 2026, shows $11.4M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GRI Bio source filings ↗